Vacancy: Marketing and Communications Officer

It is an exciting time to be joining the World Hepatitis Alliance (WHA), we have a new five-year strategy that will support and accelerate efforts to eliminate viral hepatitis globally within ten years. Alongside the new strategy, we have a new brand, a new website and a new suite of exciting campaigns, programmes and events including the World Hepatitis Summit. Communications is a key pillar of our work; the lack of awareness of hepatitis is costing people their lives, the communications team looks to work with our global membership and partners to address this. If you want to join a small, ambitious and dynamic team that works at a global level to make a difference, then this role is for you.

We are looking for someone to work closely with the Marketing and Communications Manager and other key staff, to position the organisation and the hepatitis cause within the global health landscape.

The successful candidate will deliver high impact multi-channel global campaigns, develop case studies and communicate the work of WHA to key stakeholders. We are looking for a communications all-rounder with skills across web development, copywriting, marketing, content creation and social media. The ideal candidate will be a proactive, creative problem solver ready to turn their hand to a wide range of projects.

In return, you will enjoy our innovative four-day/32-hour working week, a generous annual leave allowance, up to 5% matched pension contribution, and the chance to make a real difference to the lives of people affected by viral hepatitis around the world.

POSITION IN ORGANISATION

Reports to:                    Marketing and Communications Manager

Salary: £31,000.00

Location: Hybrid, with London office and remote working. Some international travel may be required (less than 5%).

 

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close